Mattel announced this week the launch of its first-ever Type 1 diabetes Barbie doll, adding a new character to the Barbie ...

MIT engineers developed an implantable reservoir that can remain under the skin and be triggered to release glucagon when ...

SEOUL, SOUTH KOREA - Media OutReach Newswire - 9 July 2025 - Health2Sync, Asia's leading digital chronic disease management platform, announced the successful integration of Smart Cap Mallya® for ...

Indian astronaut Shubhanshu Shukla is currently on the International Space Station. He launched as part of Axiom Mission 4.

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a ...

The insulin pens market is witnessing significant growth due to the increasing prevalence of diabetes worldwide and the rising preference for advanced, user-friendly insulin delivery systems. Insulin ...

Insulin pens are a popular and convenient blood sugar management tool for people with diabetes. They make it simple to measure and deliver insulin and are portable and convenient for travel.

The global insulin delivery pens market size is predicted to increase from USD 25,578 million in 2025 and is anticipated to reach around USD 58,086 million by 2034, expanding at a CAGR of 8.2% ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections.

As sales of Novo Nordisk’s GLP-1 drugs for diabetes and obesity continue to soar, the Danish drugmaker is once again adjusting its insulin production priorities. | Citing "capacity constraints ...

Uptake of insulin pens in LMICs is lower. A 2019 survey found 17% of diabetes centers in LMICs were using pens. Syringes remained the dominant delivery format and almost all countries reused needles.

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard for treating diabetes patients. Dr Vincent Simpson aims to cut down on ...